Download our educational materials to learn about inflammatory biomarkers and their association with atherosclerosis
The risk of developing cardiovascular disease has traditionally been assessed by measuring LDL cholesterol and HDL cholesterol. However, approximately 50% of patients hospitalized with coronary artery disease have normal LDL cholesterol levels.1
Assessing specific inflammatory biomarkers can help identify atherosclerotic risk, presence, or disease activity, for improved cardiovascular disease risk stratification.
Our educational materials offer best practices to help you assess specific inflammatory biomarkers associated with progression of atherosclerosis. Download your materials now.
Reference
1. Sachdeva A, et al. doi: 10.1016/j.ahj.2008.08.010
Download this brochure to learn more
By submitting this form, you agree to have your contact information passed along for the purpose of following up on your interests and in order to receive communications regarding Quest products, services, and events. The data sent will be processed in Canada and provided to Quest who will assume responsibility for processing and Opt-out and Information Removal. For more information, please read our Terms of Use, Privacy, Opt-out & Information Removal.